Akèy › Maladi Dijestif › Alabama › Birmingham
Etid klinik pou Maladi Dijestif nan Birmingham, AL
3 etid pou Maladi Dijestif ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Product Surveillance Registry
Ap rekriteEtid obsèvasyon
- Birmingham, Birmingham
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Ap rekriteFaz 3
- 89bio Clinical Study Site, Birmingham
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Ap rekriteFaz 3
- 89bio Clinical Study Site, Birmingham
- 89bio Clinical Study Site, Homewood · 3 mi lwen
Etid Maladi Dijestif nan lòt vil
- Chicago, IL8 etid
- New York City, NY8 etid
- Houston, TX8 etid
- Washington, DC6 etid
- San Diego, CA6 etid
- Durham, NC6 etid
- Boston, MA6 etid
- St. Louis, MO5 etid
- Seattle, WA5 etid
- Louisville, KY5 etid
- Rochester, MN5 etid
- Nashville, TN5 etid
Lòt etid nan Birmingham
- Kansè (tout kalite)30 etid
- Kansè nan tete24 etid
- Obèsite23 etid
- Kansè ovè23 etid
- Kansè Poumon ki pa ti selil22 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip18 etid
- BPCO17 etid
- Maladi kadyovaskilè17 etid
- Sipwa16 etid
- Kansè Endomèt16 etid
- Dyabèt Tip 216 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.